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Background. Given that clinical evaluation may underestimate the joint damage and that early treatment can slow down psoriatic
arthritis (PsA) progression, screening psoriasis patients with imaging tools that can depict early PsA changes would entail clear
beneﬁts. Objective. To compare the ability of X-ray and ultrasound (US) examination in detecting morphological abnormalities
consistent with early PsA in patients with psoriasis, using rheumatological evaluation as the gold standard for diagnosis. Methods.
Patients with chronic plaque psoriasis and no previous PsA diagnosis attending our outpatient dermatology clinic and reporting
ﬁnger/toe joint and/or tendon pain underwent X-ray and US evaluation; they were subsequently referred to a rheumatologist for
clinical examination and review of imaging ﬁndings. Results. Abnormal US and/or X-ray ﬁndings involving at least one ﬁnger
and/or toe (joints and/or tendons) were seen in 36/52 patients: 11 had one or more X-ray abnormalities, including erosion, joint
space narrowing, new bone formation, periarticular soft tissue swelling, and periarticular osteoporosis; 36 had suspicious changes
on US. Conclusion. US proved valuable in detecting joint and/or tendon abnormalities in the ﬁngers and toes of patients with
suspicious changes. The dermatologist should consider US to obtain an accurate assessment of suspicious ﬁndings.
1.Introduction
Psoriatic arthritis (PsA) is a form of inﬂammatory arthritis
associated with psoriasis. It aﬀects 7% to 36% of psoriatic
patients in diﬀerent samples and up to 1% of the global
population [1–8]. Moll and Wright originally described ﬁve
clinical manifestations of PsA: predominantly distal inter-
phalangeal joint disease, asymmetrical oligoarthritis, pol-
yarthritis, spondylitis, and arthritis mutilans [9]. Recently,
the classic spectrum has been extended to encompass a
number of extra-articular clinical manifestations including
enthesitis (tenderness, warmth, and/or loss of function at
the insertion of Achilles tendon, plantar fascia, and lateral or
medial epicondyle), tendonitis, tenosynovitis, and dactylitis
(swelling of the entire digit or “sausage digit”) [10, 11].
Although PsA is commonly considered as a benign arthropa-
thy, about 50% of patients go on to develop progressive
arthritis, with joint function impairment or loss and even
deformity [12–14].
PsA develops after the cutaneous disease in approxi-
mately 70% of patients, simultaneously in 10%–15%, and
before psoriasis in 15%–20% of cases [3, 12]. Since, in
most patients psoriasis predates PsA onset by about 10
years [12], the dermatologist has a crucial role in early
diagnosis, since each visit oﬀers the opportunity to assess
the joint pain that can suggest PsA. Clearly, a close working
relationship between dermatologist and rheumatologist is
the best premise for prompt PsA diagnosis and treatment
[3, 4]; however, referral of all psoriatic patients with mus-
culoskeletal pain to a rheumatologist would be impractical.
Given that clinical evaluation may underestimate the joint
involvement in these patients [15] and the high prevalence
of undiagnosed cases of active PsA that has been reported
among psoriasis patients followed by dermatologists [16],2 Clinical and Developmental Immunology
their screening with imaging tools that can depict early
PsA changes would be very helpful. Such screening would
identify those patients needing rheumatological evaluation,
whileallowingimmediateinitiationoftreatmentforthejoint
condition, as suggested by the rheumatologists [17].
Plain radiographs are the standard technique employed
to document the typical proliferative and destructive bone
lesions of PsA and are, therefore, very useful. However,
they are insensitive to the soft tissue changes (peripheral
joint eﬀusion, synovium proliferation, structural abnormal-
ities in tendons and entheses, tendon sheath thickening,
and bursitis) that are the only signs of early arthritis
[18]. Ultrasonography (US) with high-frequency probes
(>10MHz) is increasingly being used for its ability and
sensitivity, compared with clinical evaluation and X-rays
[19–22], in evaluating soft tissue involvement both in early
inﬂammatory arthritis and in late disease [21–25]. Power
Doppler sonography (PDS) aﬀords visualization of small
vessel ﬂow, showing soft tissue inﬂammation and disease
activity in peripheral arthritis [19, 26–32].
We compared the ability of X-ray and US examination
to depict morphological changes consistent with PsA in the
ﬁngers and toes of psoriasis patients using rheumatological
evaluation as the gold standard for diagnosis. Patients with
chronic plaque psoriasis but without a diagnosis of PsA
attending our Outpatient Psoriasis Clinic and reporting
ﬁnger/toe pain were examined by X-rays and US and
subsequently referred to a rheumatologist for clinical eval-
uation and assessment of the imaging ﬁndings.
2.MaterialandMethods
2.1. Patients. Subjects were 52 consecutive outpatients
with chronic plaque psoriasis and ﬁnger and/or toe pain
(Group A) who were being followed at the Outpatient
Psoriasis Clinic of Policlinico “A. Gemelli” (Rome, Italy).
Inclusion criteria were age >18 years, a diagnosis of psoriasis
for at least a year, and pain involving any ﬁnger and/or toe
joint for >3 months. Exclusion criteria were a diagnosis of
PsA or other inﬂammatory joint disease, current or recent (3
months) systemic treatment for psoriasis, a recent history of
hand or foot trauma, and current engagement in heavy man-
ualwork.Theclinicalassessmentincludedthecountofﬁnger
and toe joints with joint-line tenderness, stress pain, and/or
swelling. The joint count included the metacarpophalangeal
(MCP), proximal and distal interphalangeal (PIP and DIP)
joints of ﬁngers, and the metatarsophalangeal (MTP) and
interphalangeal (IP) joints of toes (with the proximal and
distal interphalangeal joints of toes counting as one joint).
The thumb IP joint was counted as a DIP joint. The presence
ofdactylitiswasalsorecordedif“sausagedigit”wasobserved.
Patients underwent X-ray and US evaluation of ﬁngers and
toes within two weeks of the clinical assessment and were
then referred to a rheumatologist for a deﬁnitive diagnosis.
Clinical and US evaluation of ﬁngers and toes was also
performed in 50 sex- and age-matched patients with chronic
plaque psoriasis but no ﬁnger and/or toe joint pain meeting
the same inclusion and exclusion criteria (Group B). In this
Table 1: Clinical characteristics of the study population (mean ±
SD).
Group A
(52pts)
Group B
(50pts)
Age (years) 36.2 ±9.63 2 .1 ± 10.6
PASI 9.6 ±11.57 .9 ±13.4
Mean duration of
psoriasis (yrs) 10.4 ±8.28 .1 ± 7.5
Swollen joints (no.) 0.8 ±2.10
Tender joints (no.) 2.3 ±3.10
group, abnormal US ﬁndings involved X-ray examination
and referral to the rheumatologist.
Age at psoriasis onset was recorded in both groups of
patients. The severity of psoriasis was evaluated with the
Psoriasis Area and Severity Index (PASI).
2.2. Ultrasound and Power Doppler Examination. The US
andPDSexaminationwasperformedbytwomusculoskeletal
radiologists (N.M. and L.B.), who were unaware of patients’
clinical and X-ray data. All joints and tendons of all
ﬁngers and toes were examined using a Toshiba Aplio
XV machine with a multifrequency linear transducer (5–
12MHz), 500Hz pulse repetition frequency, colour printer,
and Doppler signal recording, independently of the site(s)
of pain. Frequency was based on the joint being examined.
The colour gain was set so as to prevent ﬂash artefacts from
stationary tissue. All MCP, PIP, DIP of ﬁngers and MTP
of toes were investigated; the PIP and DIP of toes were
recorded as one joint per toe, as in the clinical evaluation.
Longitudinal and transverse views from the dorsal and the
palmar/plantar aspect were taken with the hand and foot in
neutral position. Representative images of each joint were
obtained in B mode and power Doppler mode. Flexor and
extensor tendons of ﬁngers and toes were studied in the
sameway.Jointeﬀusion,synovialproliferation,tenosynovitis
(eﬀusion of tendon sheath), and erosion of bone contour
on US were considered as being suggestive of PsA. Vascular
spots in intra-articular or peritendinous spaces on PDS were
considered as being suspicious for abnormal synovial tissue
vascularity (inﬂammation).
2.3. Radiographic Examination. Standard radiographs of
hands and feet were obtained in dorso-palmar and oblique
views and evaluated separately by the two radiologists,
who were blind to the clinical and US/PDS data. In case
of disagreement a consensus was reached by consulting
a third radiologist. Erosion, joint space narrowing, new
juxta-articular bone formation, periarticular soft tissue
swelling, and periarticular osteoporosis were considered to
be suggestive of PsA.
3. Results
3.1. Psoriatic Patients with Finger and/or Toe Pain (Group A).
Patient’s clinical characteristics are reported in Table 1 as
mean ± SD. Group A patients were 30 men and 22 womenClinical and Developmental Immunology 3
Table 2: Results of gray-scale US, PDS, X-rays, and rheumatological evaluation of 52 psoriatic patients with suspected psoriatic arthritis of
ﬁngers and/or toes.
Imaging ﬁndings suspicious for PsA
US (tot 36) PDS (tot 32) X-rays (tot 11)
Patients diagnosed with PsA by the rheumatologist (tot 36) 36 29 11
Patients not diagnosed with PsA by the rheumatologist (tot 16) 060
(36.2 ± 9.6 years), who had a duration of the skin disease of
10.4 ± 8.2 years and a PASI score of 9.6 ± 11.5. On clinical
evaluation, they had 0.8 ± 2.1s w o l l e na n d2 .3 ± 3.1t e n d e r
joints. One patient had dactylitis in one ﬁnger and three
patients had dactylitis in one toe.
Abnormal B mode (Figure 1) US ﬁndings suggestive of
PsA in at least one ﬁnger and/or toe (joints and/or tendons)
were seen in 36/52 patients. Twenty-nine of these 36 patients
showed an increased vascularity on PDS in intra-articular
and/or peritendinous spaces (Figure 2); 11 also had one or
more X-ray abnormalities. In particular, tenosynovitis with
vascular spots was detected in the ﬂexor tendons of the
aﬀected digits in the 4 patients with dactylitis; in one of these
patients, this was associated with eﬀusion in a PIP joint. All
36 patients were diagnosed with PsA by the rheumatologist.
The results of US, X-ray, and rheumatological evaluation of
Group A subjects are summarized in Table 2.
The 16/52 patients without ﬁndings suspicious for PsA
were diagnosed by the rheumatologist with osteoarthritis
(n = 11) and metabolic disease (n = 1); microtrauma pain
was suspected in the remaining 4 patients. Six of these 16
subjects also had vascular spots on PDS.
3.2. Psoriatic Patients without Finger and/or Toe Pain
(Group B) . The clinical characteristics of Group B subjects
are reported in Table 1 as mean ± SD. They were 23 men
and 27 women (age 32.1 ± 10.6 years) with a slightly but
not signiﬁcantly shorter disease duration (8.1 ± 7.5y e a r s )
compared with Group A patients. Their PASI score (7.9 ±
13.4) was comparable to that of Group A. None of these
patients had dactylitis or any tender and/or swollen joint
on clinical evaluation, or any ﬁnger and/or toe abnormality
suggestive of PsA on US. Vascular spots on PDS examination
were found in one toe joint in 3/50 subjects, and were not
held to be related to a joint disease by the rheumatologist,
but were interpreted as false positives depending on probe
sensitivity or induced by microtrauma. However, 2 patients
inthisgroupwerediagnosedwithPsAbasedonconcomitant
axial involvement (not shown).
4. Discussion
The heterogeneous clinical manifestations and course of
PsA make diagnosis particularly elusive. Most patients
experience progression of the clinical damage, while some
20% go on to develop a severe and debilitating form of
arthritis [33, 34]. Since PsA arises most frequently after
or concomitantly with psoriasis, and since early diagnosis
and treatment can prevent progression and disease-related
Figure 1: US scan. Index ﬁnger ﬂexor tenosynovitis with ﬂuid and
thickening, suggesting PsA.
Figure 2:US-PDSscan.Indexﬁngerﬂexortenosynovitiswithﬂuid,
thickening, and vascular spots.
disability, dermatologists need to be alert to its early changes
and to be aware of its clinical and imaging characteristics.
Active PsA inﬂammation frequently involves the synovial
membrane of ﬁnger and toe joints and/or tendons. US
has recently been demonstrated to depict reliably the early
changes and soft tissue abnormalities of inﬂammatory
arthritis [25, 35–44]. Some authors have shown that it
has acceptable speciﬁcity for overall joint pathology in
aﬀected and clinically unaﬀected hand and foot joints of
patients with PsA, despite being less sensitive than magnetic
resonance (MR); however, US is more widely available and
economical [44].
In the majority of our patients with psoriasis and
peripheral joint pain but no diagnosis of PsA, US showed
ﬁndings consistent with synovitis and/or tenosynovitis in at
least one ﬁnger and/or toe. X-ray evaluation disclosed
structural damage in 11 patients who also had US
abnormalities. While arthropathy was documented on
standard radiographs in 11/36 patients, all the patients with
US abnormalities, including those without pathological4 Clinical and Developmental Immunology
X-ray changes, had PsA conﬁrmed by the rheumatologist.
A larger number of soft tissue changes that were eventually
diagnosed as PsA were found on US examination than on
plain radiographs. These ﬁndings conﬁrm previous reports
of the ability of US to depict inﬂammatory and destructive
changes in the ﬁngers and toes of PsA patients [19, 44].
The majority of our patients who had abnormalities on
US also had clear vascular spots in intra-articular and/or
peritendinous spaces on PDS, reﬂecting an active inﬂamma-
tory disease. In six Group A patients, the PDS signal was not
judged to be related to PsA, given their normal morphologi-
cal US and X-ray ﬁndings. Although a PDS signal at the level
ofthesynoviumiswidelyconsideredasasignofhyperhemia,
it is, in fact, also seen in some normal joints, especially
when using highly sensitive devices. Terslev and coworkers
found vascular spots in 11% of wrist and ﬁnger joints in 28
healthy subjects and concluded that PDS positivity per se
should not be considered as a sign of inﬂammation. Since
the synovial proliferation and/or eﬀusion typical of chronic
synovitis on gray-scale US may be undetectable in very
early disease, a cut-oﬀ for vascular spots could be deﬁned
above which inﬂammation should be deemed to be present
[45]. Such considerations may also explain the positive PDS
ﬁndings seen in three Group B subjects who had increased
vascularity on PDS. Thus, despite its high sensitivity, PDS
lacks speciﬁcity in detecting diagnostic features of PsA and
should be integrated with an accurate morphological US
study, to demonstrate any inﬂammatory changes.
Finally, the psoriatic patients who were diagnosed with
PsA and those in whom the disease was excluded had
comparable demographic and clinical features (not shown),
conﬁrming that the cutaneous and the joint disease have
independent courses.
US proved valuable in detecting synovium abnormalities
in the ﬁngers and toes of patients with suspected PsA. The
dermatologist,whousuallymanagespsoriaticpatientsbefore
the onset of the joint disease, should consider US to obtain
an accurate assessment of suspicious ﬁndings, especially in
presence of early changes. Although concomitant vascular
evaluation by PDS did not seem to improve the ability of
US to depict early PsA changes, the additional information
on disease activity provided by PDS may be useful to assess
response to therapy [31, 32].
Since US does not depict the speciﬁc changes of PsA,
clinical and imaging ﬁndings suspicious for psoriatic joint
disease should be assessed jointly by the dermatologist
and the rheumatologist—whose cooperation is in our view
always desirable—to classify psoriatic patients with joint
abnormalities and to select the most appropriate treatment
for both the skin and the joint disease.
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